Dohern Kym, Department of Surgery and Critical Care, Burn Center, Hangang Sacred Heart Hospital, Hallym University Medical Center
12, Beodeunaru-ro 7-gil (Yeongdeungpo-dong 7-ga 94-200), Yeongdeungpo-gu, Seoul, Korea, (Zip 07247)
Tel: +82-02-2639-5446,5438, Fax: +82-02-2678-4386
E-mail: dohern@hallym.ac.kr, dohern@hallym.or.kr
The goal of the Journal of Korean Burn Society (J Korean Burn Soc) is to inform members of the
burn team of significant advances in burn research, education, delivery of acute care, rehabilitation,
and prevention. Authors are invited to submit original articles on any aspect of burn care or
rehabilitation for publication. The journal shall be issued on June 1 and December 1, twice a year.
Authors are encouraged to submit manuscripts online through the Journal’s Web site at
www.kburnj.or.kr. Manuscripts must be written in Korean or English. If the details are not described
below, the style should follow the Uniform Requirements for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publications available at International Committee of
Medical Journal Editors (ICMJE) website (http://www.icmje.org).
Research and publication ethics
Copyright
Manuscript submission
Publication Fee
Review process
Manuscript preparation
General text style
The Journal of Metabolic and Bariatric Surgery is the official journal of the Korean Society for Metabolic and Bariatric Surgery. The journal publishes significant surgical studies related to obesity and metabolic diseases. Also, it makes contributions to medical development through researches on optimal surgical treatment and standardization of metabolic and bariatric surgery. The journal also promotes active communication between and continuous encouragement of the members, so as to ensure productive research and education. Ultimately this journal wishes to contribute to the improvement of public health and the overall quality of life of human beings.
Manuscripts for submission to The Journal of Metabolic and Bariatric Surgery should be prepared according to the instructions for authors. If the details are not described below, the style should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications available at International Committee of Medical Journal Editors (ICMJE) website (http://www.icmje.org).
For the policies on research and publication ethics, follow the policies established by the 'Good
Publication Practice Guidelines for Medical Journals' (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=) or
the 'Ethical Guidelines on Good Publication' (http://publicationethics.org/resources/guidelines) or
Ethical Considerations in ICMJE (http://www.icmje.org/index.html), especially those on the
disclosure of conflicts of interest, statement of informed consent, statement of human and animal
rights, Institutional Review Board, authorship, originality, duplicate publication, and clinical trials
registry. Any attempt to duplicate publication or any fabrication, falsification and plagiarism will
lead to automatic rejection, may prejudice the acceptance of future submissions, and may be
highlighted within the pages of the journal. Submission of an article implies that the work
described has not been published, that it is not under consideration for publication elsewhere,
that its publication is approved by all authors and tacitly or explicitly by the responsible
authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere in the same form, in Korean or in any other language, including electronically without
the written consent of the copyright-holder. Accepted manuscripts become the full property of the
Korean Burn Society and may not be published elsewhere without the written consent of the
publisher.
Readers are urged to respond to articles and to share ideas about burn care. Editors reserve the
right to edit letters without changing meaning. All letters must be signed; no anonymous
correspondence will be published.
An author is considered as an individual who has made substantive intellectual contributions to a published study and whose authorship continues to have important academic, social, and financial implications. The ICMJE has recommended the following criteria for authorship: (1) substantial contributions to conception and design, acquisition, analysis, and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet criteria 1, 2, 3, and 4. These criteria are applicable to those journals that distinguish the authors from other contributors.
All contributors who do not meet the criteria for authorship should be listed in an acknowledgments
section. All persons who have contributed materially to the paper but whose contributions do not justify
authorship may be listed under a heading such as "clinical investigators" or "participating investigators".
Manuscripts are only accepted for publication in journals if they have not been published
elsewhere. Manuscripts published in this journal should not be submitted for publication
elsewhere. If the author(s) wishes to obtain a duplicate or secondary publication for various other
reasons, such as for readers of a different language, he/she should obtain approval from the
editors-in-chief of both the first and second journal.
Conflict of interest exists when an author (or the author's institution), reviewer, or editor has
financial or personal relationships that inappropriately influence his/her actions (such relationships
are also known as dual commitments, competing interests, or competing loyalties). All authors
should disclose their conflicts of interest, i.e., (1) financial relationships (such as employment,
consultancies, stock ownership, honoraria, paid expert testimony), (2) personal relationship, (3)
academic competition, and (4) intellectual passion. These conflicts of interest must be included as
a footnote on the title page or in the acknowledgement section. Each author should certify the
disclosure of any conflict of interest with his/her signature.
The ICMJE has recommended the following statement for the protection of privacy, confidentiality, and written informed consent: The rights of patients should not be infringed without written informed consent. Identifying details should not be published in written descriptions, photographs, and pedigrees unless it is essential for scientific purposes and the patient (or his/her parents or guardian) provides written informed consent for publication. However, complete patient anonymity is difficult to achieve; therefore, informed consent should be obtained in the event that anonymity of the patient is not assured. For example, masking the eye region of patients in photographs is not adequate to ensure anonymity. If identifying characteristics are changed to protect anonymity, authors should provide assurance that alterations do not distort scientific meaning and editors should take note of this. When informed consent has been obtained, it should be indicated in the published article.
While reporting experiments that involve human subjects, it should be stated that the study was performed according to the Helsinki Declaration (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) and approved by the Research Ethics Committee (REC) or the Institutional Review Board (IRB) of the institution where the experiment was performed. A written informed consent should be obtained from all subjects. In the case of an animal study, a statement should be provided indicating that the experiment process, such as the breeding and the use of laboratory animals, was approved by the REC of the institution where the experiment was performed or that it does not violate the rules of the REC of the institution or the NIH Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, http://www.nap.edu/readingroom/books/labrats/index.html). The authors should preserve raw experimental study data for at least 1 year after the publication of the paper and should present this data if required by the editorial board.
Any research that deals with clinical trial should be registered to the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp, or other sites accredited by World Health Organization or ICMJE.
All publishing rights on the contents and manuscript will be owned by Korean Burn Society, and the corresponding author should sign the agreement on copyright and then submit it after acceptance. The person using J Korean Burn Soc online may use, reproduce, disseminate, or display the content from this journal for non-commercial purposes. Any use of the content in whole or in part must include the customary bibliographic citation, including author and publisher attribution, date, article title, J Korean Burn Soc and the URL, and must include a copy of the copyright notice. If an original work is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work, this must be clearly indicated. For any commercial use of material from the journal, permission must be obtained from the Korean Burn Society.
All manuscripts should be submitted through the online manuscript management system available at www.kburnj.or.kr. Once you have logged into your account, the online system will lead you through the submission process in a step-by-step process. After entering all of the checklist items and information on the authors, manuscript title, abstract, keywords, and other details, you will be prompted to upload your files. Please attach any other related material with the submitted manuscript, so that the reviewers are aware of any potential overlap. Please contact the editorial office if you have difficulty in submitting a manuscript.
06208 Bestian Hospital, 429 Dogok-ro, Gangnam-gu, Seoul, Republic of Korea
Tel: +82-70-7609-9317, Fax: +82-70-4757-1230, +82-70-7005-4233
E-mail: journal@kburnj.or.kr
Upon acceptance of an article, certain amount of fee should be paid. All images should appear in
color and all expenses related to it will be paid by the society. But, the actual cost of extra issue
and line printing, etc. will be paid by the author.
The decision on the acceptance of unsolicited manuscripts is based on the results of a peer review
by at least two anonymous referees. To ensure unbiased review, reviewers receive manuscripts
without the authors' names. When the editorial board requests revisions, authors should complete
the revision within 4 weeks or else it will be considered as withdrawn by the author.
The manuscripts for original articles should be organized in the following order: title page,
abstract, main text, conflict of interest, acknowledgement, references, tables, figure legends, and
figures.
Preferred file formats
Preferred file formats for the main text and tables are .doc or .docx. The file format of figures
should be .doc, .docx, .jpg, .jpeg, .ppt, .pptx, .tif, or .tiff. The manuscript should be double spaced
on 21.0×29.7 cm (A4) paper with 3.0-cm margins at the top, bottom, and left. Standard font size
is 12 pt.
Cover letter
The cover letter should address the following questions:
1. Why is this manuscript suitable for publication in J Korean Burn Soc?
2. Why will your study inspire researchers or clinicians, and how will it improve patient care or
public health, or drive the understanding of disease forward?
Title page
Please state the title of the article, full name of each author, authors' affiliations, and running title.
Also include the name, postal address, telephone, FAX, and e-mail of the corresponding author,
and the place and date of any scientific meetings where the material may have been presented.
The running title must be within in English.
Abstract
The word count should not exceed 250 words in a structured format (see below). Abstract should
be written in English (not Korean) and as following order.
Purpose: State why the study was done, the main aim.
Methods: Describe patients, laboratory materials, and other methods used and the nature of
the study (randomized clinical trial, retrospective review, experimental study, etc.).
Results: State the main findings, including important numerical values.
Conclusion: State the main conclusion, highlighting controversial or unexpected observations.
Keywords: These should be listed at the bottom of the abstract to be used as index terms, 5
words or less. Medical Subject Heading (MeSH; http://www.nlm.nih.gov/mesh) terms are
highly recommended for selection of keywords.
These should be organized in the following order: title page, unstructured abstract less than 150 words in English, main text, references, tables, figure legends, and figures. The main text consists of the INTRODUCTION, CASE REPORT, DISCUSSION sections. CONFLICTS OF INTEREST and ACKNOWLEDGMENTS paragraphs may be included following DISCUSSION. Limit the number of references to 10. Otherwise, it follows the style and format of original articles.
These are organized as follows: title page, unstructured abstract less than 300 words, main text,
references, tables, figure legends, and figures. The main text consists of the INTRODUCTION,
MAIN BODY, CONCLUSION sections. CONFLICTS OF INTEREST and ACKNOWLEDGMENTS
paragraphs may be included following CONCLUSION. The number of references should be limited
to 80. Otherwise, it keeps the style and format of original articles.
It is organized as follows: title page, main text, and references. The word count should not exceed 1,000.
Verb tense: Authors should use the past tense to describe past events and data. Use the present
tense for authors' opinion and generally accepted facts.
Description of localities: The names and locations (city, [state], nation) of manufacturers of
equipment and non-generic drugs should be given. For Korean localities, refer to the
Guidelines for the Romanization of Korean localities available at
https://kornorms.korean.go.kr/regltn/regltnView.do?regltn_code=0004
Units: SI units should be used for measurements. The unit of temperature is degrees Celsius (℃).
Abbreviations: Any abbreviation must be used consistently and must be defined at the first use.
Commonly used abbreviations would be described in article without explanation. Refer to
'Abbreviation. Acnonym and Unit'.
Numbers: In the text, numbers equal to or less than nine should be written as text. Numbers
larger than nine should be Arabic numerals, except when beginning a sentence
- The unmentioned introduction should be followed by common practice.